Ubs Group Ag Pro Mis Neurosciences Inc. Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PMN
# of Institutions
17Shares Held
3.26MCall Options Held
0Put Options Held
0-
Sphera Funds Management Ltd. Tel Aviv, L31.81MShares$1.98 Million0.4% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.06MShares$1.15 Million1.49% of portfolio
-
Affinity Asset Advisors, LLC New York, NY266KShares$289,8940.05% of portfolio
-
Bank Of Montreal Toronto, A630.4KShares$33,0980.0% of portfolio
-
Hara Capital LLC Bellevue, WA29.4KShares$32,0630.03% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...